July 7, 2025 Almac completes a multi-million-pound Investment Enhancing Cold Chain Capabilities in Craigavon
June 2, 2025 Almac Group announces validated near and long-term science-based emissions reduction targets with the Science Based Targets initiative (SBTi)
May 28, 2025 Almac Group surpasses £1 billion revenue with latest Annual Accounts reporting record revenues, profit and employee numbers
May 8, 2025 Almac Clinical Services wins ‘Innovation in Distribution’ award at the Making Pharmaceuticals Awards
May 6, 2025 Almac Discovery and Formosa Pharmaceuticals announce global licensing agreement for development and commercialisation of ALM-401, a first-in-class EGFRxROR1 Bispecific Antibody-Drug Conjugate
March 26, 2025 Almac Diagnostic Services adds single cell sequencing to its lab services to further enable biopharma clients research needs
January 17, 2025 Almac invests £500,000 in state-of-the-art instrumentation within spectroscopy laboratories
December 11, 2024 Almac Acquires Your Research to expand eClinical solutions for participants, sites and sponsors
October 28, 2024 Almac Pharma Services announces recruitment event following major expansion at Craigavon HQ
July 30, 2024 Almac Announces Investment in Singapore to Enhance Cold Chain Facility for Global Pharmaceutical Sponsors and Patients
May 30, 2024 Almac Discovery nominates ALM-401 as a First in Class Bispecific Next Generation ADC targeting EGFR/ROR1 to progress into pre-clinical development
April 30, 2024 Almac Pharma Services Supports Industry Consortium to Address Titanium Dioxide Alternative Challenge
April 23, 2024 Almac Group partners with Reach Out and Read at Children’s Hospital of Philadelphia to distribute 6,000 books at CHOP Primary Care, Souderton
April 22, 2024 Amicus Therapeutics Inc and Almac Pharma Services Mark 15-year Strategic Partnership with Patient Advocacy Event
April 11, 2024 Almac Clinical Services celebrates Grace Science, LLC in dosing first NGLY1 deficient patient with their innovative gene therapy
March 27, 2024 Almac Group announces support of ESG category at this year’s Belfast Telegraph Business Awards
March 20, 2024 Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
March 6, 2024 Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity
February 6, 2024 Almac Group signs virtual power purchase agreement (VPPA) for renewable energy – reducing their global scope 2 emissions by 46%
January 25, 2024 Almac Sciences extends selectAZyme™ offering to include therapeutic oligonucleotide synthesis
November 30, 2023 Almac Group awards over $120,000 in higher education funding to two undergraduate students
November 29, 2023 Almac Discovery and Queen’s University launch state-of-the-art Chemoproteomics facility in Belfast
October 11, 2023 Almac Sciences and HydRegen successfully complete first scale up of their joint development project
August 31, 2023 Almac expands Next Generation Sequencing capabilities through investment in new Illumina NovaSeq™ X Plus instrument
August 7, 2023 Almac Group marks groundbreaking of $65 million facility expansion in Montgomery County
June 7, 2023 Almac Group reaches a global workforce of 7,000 as it marks most successful financial year ever
June 6, 2023 WEE1 Inhibitor discovered by Almac Discovery advanced into two clinical studies addressing the treatment of advanced solid tumours
May 17, 2023 Almac Diagnostic Services updates claraᵀ report with significant new content for cancer research
May 4, 2023 Almac Sciences and University College Dublin BROADEN Continuous Flow Chemistry Collaboration
April 21, 2023 Almac Appoints Global Energy Manager as part of ongoing commitment to net zero strategy
March 30, 2023 Almac Group Enters Strategic Partnership with North Carolina A&T University’s Deese College of Business & Economics
March 24, 2023 Technical Quality Team Leaders Graduate with Masters in Pharmaceutical Validation Technology
March 15, 2023 Almac Sciences successfully completes an outstanding Knowledge Transfer Partnership with QUB
February 14, 2023 Almac Pharma Services and Provention Bio, Inc Celebrate Rapid Launch of TZIELD™ (teplizumab-mzwv)
January 26, 2023 Almac Group Opens Registration for Internationally Recognised Process Chemistry Forum in Belfast
December 13, 2022 Almac Pharma Services Supports Rapid Launch of Provention Bio, Inc.’s Treatment TZIELD™ (teplizumab-mzwv)
December 6, 2022 Almac Clinical Technologies announces IXRS®3 as market leading in key industry report
December 1, 2022 Odyssey Trust invests £3 million in state-of-the-art new centre to offer Learning Innovation for Everyone
November 15, 2022 Almac Pharma Services Audubon site receives first product approval by MHRA and Health Canada
October 17, 2022 Almac Pharma Services Supports Packaging and Supply of PTC Therapeutics’ Gene Therapy Upstaza™ for EU Launch
August 24, 2022 Almac Discovered Molecule Progresses into Clinical Development with its strategic licensee Vaderis Therapeutics AG
August 18, 2022 Almac Group’s Dundalk Site Achieves Globally Recognised Health & Safety and Environmental Management System Certifications
August 11, 2022 Almac, AstraZeneca CDx Partnership Branching Out to New Disease Areas, Drawing on NGS, qPCR
August 2, 2022 Almac Group Expands Laboratory Scale Jet Milling Capabilities for Formulation and Toxicology Studies
June 23, 2022 Almac Diagnostic Services collaborates with AstraZeneca to Develop and Commercialise Companion Diagnostics (CDx)
June 16, 2022 Almac Group & Indian Valley Education Foundation Cut Opening Ribbon on Student Careers Experience Center at Souderton Area High School
June 14, 2022 Almac Group records highest ever revenue, profit and employee numbers as £200 million global expansion plans announced
June 1, 2022 Almac Discovery nominates a first candidate molecule from its Protein Drug Conjugate (PDC) Platform to progress into pre-clinical development
April 25, 2022 Almac Celebrates Earth Day with Habitat for Humanity of Montgomery and Delaware Counties
April 12, 2022 Almac Group Announces £500,000 Investment in NMR Technology to Enhance Security, Flexibility, and Capacity in Analytical Services
March 22, 2022 Almac Group Clinical Supply and Commercial Solutions Support Agios’ Road to FDA Approval
March 14, 2022 Almac Pharma Services Expands its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products
March 11, 2022 Almac supports Belfast Telegraph Business Awards Category – ‘Excellence in Corporate Social Responsibility’
March 9, 2022 Almac Group Partners with Irish American Business Chamber & Network to Promote International Business & Life Science Sector Growth in Greater Philadelphia
February 22, 2022 New paper reveals Thermodynamic Control Key to Achieving Crystallisation Goal for Psilocybin
December 16, 2021 Debiopharm Further Explores the Potential of Potent, Highly Selective WEE1 Inhibitor in Phase 1 Cancer Study
December 8, 2021 Almac Diagnostic Services’ claraT Report Assists Researchers In Uncovering New Oncology Findings
November 2, 2021 Almac Sciences and Irish Manufacturing Research Collaborate to Enhance Flow Chemistry Expertise
October 5, 2021 Almac Group Procurement Professionals Achieve Chartered Institute of Procurement & Supply (MCIPS) Designation
September 22, 2021 Almac Sciences and Queen’s University Belfast Collaboration Successfully Flows Through Mid-point
July 28, 2021 Almac Clinical Technologies and THREAD Partner to Eliminate Common Clinical Trial Delays
July 14, 2021 Almac Group Announces Innovative Community-Based Partnership with Indian Valley Education Foundation
July 6, 2021 Almac Group’s Charnwood Site Achieves Globally Recognised Health & Safety and Environmental Management System Certifications
May 25, 2021 Almac Group invests £325,000 as part of Stage 1 entry into continuous flow manufacturing
April 14, 2021 Almac Group Appoints Julie Shannon as Vice President and Deputy Head of Information Services
March 25, 2021 Almac Group Awarded ISO Certification for Integrated Safety and Environment Management System
January 27, 2021 Almac Group Launches Scholarship Fund, Will Award $50,000 to Triangle Student in 2021
January 18, 2021 Professor Daniel Longley Joins Almac Discovery to Accelerate Colorectal Cancer Research
January 12, 2021 Almac Group Awarded £Multimillion R&D Grant to Accelerate Enzyme Discovery Unique INSIGHT™ project builds on Almac’s existing enzyme expertise
January 11, 2021 Personal Genome Diagnostics and Almac Diagnostic Services Enter Strategic Collaboration to Enhance Patient Care in Oncology
December 10, 2020 Almac Group Granted Phase I Award Under the ‘Sustainable Innovation Fund’ to Aid COVID-19 Recovery
November 17, 2020 Almac Group Works to enable efficient manufacturing of remdesivir in Response to COVID-19
November 4, 2020 Almac Group Continues HLA Scheme for Aspiring Scientists, Technologists and Engineers
September 30, 2020 Almac Group Ranked Second in Belfast Telegraph’s “Businesses making the largest contribution to incomes” Table
September 8, 2020 Arran Chemical Company Continues Unique Industry – Academia Collaboration with Athlone Institute of Technology
September 2, 2020 Almac Group Donates a Quarter of a Million Pounds to Global Charities in Wake of COVID-19
June 18, 2020 Almac Discovery to Present Updates on Key Oncology Programmes at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
June 4, 2020 Almac Group Welcomes Confirmation that Northern Ireland’s Pharmaceutical Industry will Maintain Regulatory Alignment with the EU Post-Brexit
June 1, 2020 Almac Clinical Technologies Introduces SimplifyTM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up
May 14, 2020 Almac Discovery Enters Into Licensing Agreement for the Development & Commercialisation of ALM301
March 31, 2020 Self-administered pain-killer saves patient time and NHS resources in accident and emergency departments
February 18, 2020 Almac Clinical Services’ Just in Time Manufacturing Operations Pass EU Regulatory Inspection
February 12, 2020 Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK
January 28, 2020 Almac Group to Host West Coast Lunch and Learn Workshop Series on Adaptable Clinical Supply Chain Strategies for Biologics
January 22, 2020 Almac and Pfizer celebrate success of patient-led clinical supply model in gene therapy trial
January 8, 2020 Galen, an Almac Company, announces Completion of Multi-Million Pound POA Pharma Acquisition
September 26, 2019 Almac’s unique gene expression report enables cancer researchers to discover exciting new insights
August 5, 2019 Almac Group to Host EU Product Launch Workshop Series in California and Washington States
July 31, 2019 Almac Group Invites Biopharma Industry Members to Learn About Almac Adapt™ – Just in Time Manufacturing at Complimentary Workshop
July 8, 2019 Arran Chemical Company forms Unique Industry – Academia Collaboration with Athlone Institute of Technology
June 5, 2019 Almac Group Announces CE Mark of Diagnostic Assay to Support Turning Point Therapeutics’ Pivotal TRIDENT-1 Clinical Trial
May 6, 2019 Turning Point Therapeutics and Almac Diagnostic Services announce approval of an investigational device exemption for the companion diagnostic assay to the registrational TRIDENT-1 clinical study
April 18, 2019 Almac Group Partner with Queen’s Researchers to pioneer potentially life-changing oesophageal cancer test
April 8, 2019 Almac Group Publishes Comparison Report on Automated vs Paper based Accountability & Reconciliation
March 27, 2019 Almac Group Launches Upgraded Version of claraT – A Unique, Software-driven Gene Expression Report
March 20, 2019 Almac Discovery and Elasmogen to Share Anti-ROR-1 VNAR Data at American Association of Cancer Annual Meeting
March 18, 2019 Almac Discovery Showcases its Deubiquitinase Drug Discovery Expertise at the American Association of Cancer Research Annual Meeting in Atlanta
February 25, 2019 Almac Group Engages with Science Exchange to Promote US Small Molecule Analytical Services
February 20, 2019 Almac Group to host Clinical Trial Supply Lunch and Learn Workshop in San Francisco
December 14, 2018 Almac Group Invites Attendees to Join Workshop in San Diego to Learn About Cold Chain Management in Clinical Trials
October 25, 2018 Almac Group Receives Board of Trade Award by the United Kingdom’s Department of International Trade (DIT)
October 24, 2018 Almac Group Scoops Research & Development Achievement at 2018 Irish Pharma Industry Awards
October 24, 2018 TP Therapeutics and Almac Diagnostic Services Enter into Agreement to Develop Next-Generation Sequencing, Pan-Cancer Companion Diagnostic
October 11, 2018 Almac Group Invests in Cutting Edge Next Generation Sequencing Capabilities for Bio Pharma Clients
September 10, 2018 Almac Group to host Clinical Trial Supply Lunch and Learn at North American Headquarters
August 21, 2018 Almac Group Appoints Jonothan Cooil as Vice President of Engineering, Facilities and Health, Safety & Environment
July 25, 2018 Almac Clinical Technologies Releases New Podcast Series Entitled “Spotlight on IRT: Best Practices”
July 16, 2018 Almac Group Invests in NMR Equipment to Enhance Existing Analytical Services Capability
July 6, 2018 “Portadown Gets Active” A summer scheme to support local children and end holiday hunger
May 29, 2018 Almac Group’s Vice President of Global Business Development Appointed to British American Business Council of Greater Philadelphia (BABCPHL) Board of Directors
April 27, 2018 Almac Group leads key workshops at the upcoming Global Clinical Supplies Group Conference (GCSG) in Atlanta, GA
April 20, 2018 Almac Group Receives Recognition at The Irish Laboratory Awards with Laboratory Supplier of the Year Award
April 18, 2018 Almac Group Continues to Share Expertise as part of North America “Lunch & Learn” Seminar Series
April 16, 2018 Almac Diagnostic Services Validates Illumina TruSight® Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials
February 12, 2018 Almac Diagnostic Services Partners with DNAnexus to Power Clinical Trial Assay Development
January 23, 2018 Almac Group Implements Salesforce Service Cloud to Enhance Client and Clinical Site User Experience
December 5, 2017 Almac Group Receives Annual Industrial Award from the Institute of Chemistry of Ireland
November 13, 2017 Almac Clinical Technologies’ President & Managing Director Keynotes Life Sciences PA’s CRO & CMO Summit
November 2, 2017 Almac Group’s US Financial Controller Appointed to Irish American Business Chamber & Network (IABCN)’s Board of Directors
November 1, 2017 Veeva Systems Inc.: Veeva Announces Partner Approach for Best-in-Class Randomization and Trial Supply Management
October 23, 2017 Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment
October 16, 2017 Almac Pod™ – Changing the Global Dynamics of Temperature Controlled Shipping Solutions
March 8, 2017 Almac Diagnostic Services and EORTC Establish Collaboration for Tumour Molecular Profiling
February 28, 2017 Irish Ambassador to US will present distinguished awards to Beneficial Bank, Eileen McDonnell, and Sean Rooney
February 16, 2017 Almac Diagnostic Services Appoints Dr Leeona Galligan as Vice President UK Operations
January 26, 2017 Almac Group Announces Further Global Expansion as it Secures New Premises in Republic of Ireland
December 15, 2016 Almac Group Collaborates with Exostar to Extend Clinical Trials Identity Management
December 13, 2016 Almac Group Appoints Professor Tom Moody as VP of Technology Development and Commercialisation
November 17, 2016 Almac Group Team Up with Irish American Business Chamber & Network for Life Sciences Forum
November 14, 2016 Almac Group Expands Commercial Capabilities to Meet Industry Demand for Paediatric Formulations
October 10, 2016 Almac Group Discover an Exciting Link between its Immune Response Assay and Checkpoint Inhibitor Based Therapy
September 20, 2016 Almac Group Celebrates 20 Years in North America with $5.2 million Expansion Creation of 79 Additional Jobs in North Carolina
August 8, 2016 Almac Publish Second Validation of Stage II Colon Cancer Recurrence Assay in the Journal of Clinical Oncology
August 2, 2016 Almac Group’s Integrated Development to Commercialisation Services Support Amicus Therapeutics’ First Commercial Orphan Drug Product
July 14, 2016 Almac Group’s Rapid Launch Services Support U.S. Approval of Intercept Pharmaceutical’s First Commercial Orphan Drug Product
June 8, 2016 Almac Diagnostic Services Expand Companion Diagnostic Development Service Offering with NanoString Barcoding Technology
April 25, 2016 Almac Clinical Technologies Announces Participation in the Avoca Diligent Prequalification Platform
November 12, 2015 Almac Group to Collaborate with Illumina on Next-Generation Sequencing Based Companion Diagnostic Development
October 7, 2015 Almac Group Addresses Industry Demand for Multiparticulate Drug Products with Scalable Fluid Bed and Encapsulation Technologies
September 9, 2015 Almac Group’s Integrated CMC Services Support US Approval of Wellstat Therapeutics’ First Commercial Orphan Drug Product
September 7, 2015 Almac Group’s Asia Pacific Headquarters Receives Official Health Science Authority (HSA) Accreditation
July 10, 2015 Almac Group Expands Asia Pacific Presence with New Regional Headquarters and Clinical Trial Supply Facility in Singapore
July 10, 2015 Almac Group Named UK Trade & Investment Winner in Final of the European Business Awards 2014/5
March 11, 2014 Almac Expands Asia Pacific Operations, Establishes Regional Operations Center in Singapore
January 28, 2014 Data Presented Supporting Almac Developed Colon Signature as a Significant Predictor of Risk of Recurrence in Stage II Colon Cancer
January 21, 2014 Almac publishes breast cancer chemotherapy response assay in the Journal of the National Cancer Institute
November 26, 2013 Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
November 18, 2013 Almac Further Enhance 3rd Party Logistics Commercial Support Services for Niche / Orphan Drugs
October 22, 2013 Novozymes Biopharma announces collaboration with Almac in Drug Manufacture, Half Life Extension and Targeting Technologies
September 23, 2013 Almac Launches SupplyTraQ™ Technology Solution to Streamline Clinical Trial Supply Administration
July 2, 2013 Almac Introduce Contained Drug Handling and Bottling Capabilities in EU and US Clinical Services Sites
June 7, 2013 Almac Employees Reward Macmillan Belfast, Mindwise Lurgan and Craigavon’s Neonatal Unit in Annual Charity of Choice Survey
February 13, 2013 Almac to deliver insight into Supply Chain Management at Clinical Trial Supply Europe Event
February 6, 2013 Almac launches US commercial packaging operations with successful FDA inspection and new client partnership
January 21, 2013 Almac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade
October 10, 2012 Almac increase early phase ‘hit to lead’ chances with Pre-Clinical Screening Packages
October 3, 2012 Almac expands UK commercial capacity with the acquisition of new blistering technology
August 21, 2012 Almac announces launch of Next Generation Sequencing service for personalised medicine
August 8, 2012 Almac Streamline Temperature Sensitive Clinical Supplies with Enhanced Service Offering
July 18, 2012 US Consul General applauds Almac’s economic contribution to the US pharmaceuticals market
June 11, 2012 Almac and VTU Technology form collaboration to provide customers with high yielding, fast-track generation of site-specific modified products
March 12, 2012 Almac adds aXcess™ to its suite of services to complement clinical packaging and distribution bundle
February 28, 2012 Almac Boosts Capacity and Productivity with Acquisition of New Encapsulation Equipment
November 30, 2011 Almac’s Diagnostic Laboratory Receives Accreditation from College of American Pathologists
November 21, 2011 Almac Responds to Alexion’s Request for Rapid Packaging and Distribution During Public Health Crisis in Germany
November 8, 2011 Almac publishes Stage II colon cancer recurrence signature in the Journal of Clinical Oncology
October 5, 2011 Almac and Greenphire Form Alliance to Deliver Direct-to-Patient Stipend Payments Through IXRS®
September 8, 2011 Almac takes a clinical approach – Almac CEO Alan Armstrong talks about the firm’s continuing expansion
June 30, 2011 Almac Expands Global Coverage by Adding Depots for Clinical Trial Supply Distribution to the Asia Pacific Region
June 17, 2011 Almac to Feature New Enhancements to its Integrated Supply Chain Management and Patient Compliance Services at the Annual DIA Meeting in Chicago
May 20, 2011 Almac celebrate official opening of North American HQ with former US. Senator George Mitchell
May 11, 2011 Almac to host inaugural European Product Launch workshop for US Biopharmaceutical Companies
March 25, 2011 Almac announces expansion to its commercial facility with the addition of increased storage capacity for biologic products
March 23, 2011 Almac to Demonstrate New Patient Management Services at the Euro DIA and Partnerships in Clinical Trials Conferences
February 14, 2011 Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference
January 19, 2011 Distribution Heats Up as Almac Continues its Transition to New North American Headquarters
November 26, 2010 Almac adds Late Stage Customisation Suite to assist Orphan Drug / Niche Product Launches into Europe
November 23, 2010 Almac discusses its investment in biocatalysis lauding cost and environmental benefits on OutsourcingPharma.com
November 19, 2010 Almac and the Royal Society of Chemistry host a workshop on the use of analytical techniques to control and monitor solid form
November 10, 2010 Almacs Clinical Technologies Business Unit Again Receives `Best Places to Work in PA 2010′ Award
October 13, 2010 Almac Successfully Moves its Clinical Technologies Business Unit into New North American Headquarters
September 21, 2010 Almacs Clinical Technologies Division undergoes successful joint GCP-GMP MHRA Inspection
June 28, 2010 Almac Announces Collaboration with Aeterna Zentaris to Develop Therapy and Companion Diagnostic in Cancer
June 23, 2010 Special Recognition Accolade posthumously awarded to Sir Allen McClay, Founder of Almac
June 14, 2010 Almac completes £2 million client sponsored investment expanding commercial sacheting capacity
April 12, 2010 Almac partners with Merck KGaA and the MRC to assess markers of response to Cetuximab therapy
April 7, 2010 Almac wins Excellence in Innovation Category at Tenth Annual Belfast Telegraph / BMI Northern Ireland Business Awards – Read more.
April 7, 2010 New FLEXYTE® Protease Assays Enable Information-rich Output, Miniaturization and Multiplexing
March 17, 2010 Almac and Queens University Belfast showcase Northern Irish ‘oncology hub’ to senior Washington DC delegates
February 17, 2010 Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
February 10, 2010 Almac adds Xcelodose® 600S Precision Powder Micro-dosing System to its Product Development Capabilities
January 18, 2010 Almac Announces that AstraZeneca is to Undertake Evaluation FLEXYTE Protein Kinase Assays
December 7, 2009 Almac Clinical Technologies Announces Patient-Reported-Outcomes Partnership with FACIT.org
October 13, 2009 Almac and Edinburgh Instruments launch of FLEXYTE fluorescence lifetime assays at MipTec
July 28, 2009 UM Breast Cancer Researchers partner with Almac to win prestigious Department of Defense Grant
July 15, 2009 Almac Group Continues Aggressive Hiring Campaign in PA to Meet Growing Demand from Pharma and Biotech Customers
June 2, 2009 Almac and Middlebrook Pharmaceuticals discuss their successful partnership in Tablets and Capsules
May 18, 2009 Almac Announces Collaboration with Pfizer and the PETACC3 Translational Research Working Party
February 13, 2009 Almac Continues Global Expansion of Clinical Supply Services with Huge Facility for Specialist Storage
February 5, 2009 Almac Pharma Services Retained by MiddleBrook Pharmaceuticals to Produce Physician Samples of MOXATAG
January 26, 2009 Intelligroup Secures Multi-Million Dollar COSMOS Implementation with Almac Clinical Services
December 1, 2008 Almac Clinical Services milestone achievement as full GMP compliance achieved across global sites
July 31, 2008 Almac Announce World’s Largest Gene Expression Study To Develop Prognostic Test for Early Non Small Cell Lung Cancer
July 24, 2008 Governor Rendell and Sir Allen McClay break ground at site of new Almac North American headquarters
May 20, 2008 Almac Clinical Technologies signs contracts for a number of large, complex Clinical Trials
May 8, 2008 Almac Diagnostic Services in new deal to provide unique process to extract genetic information from Clinical Trial samples
March 31, 2008 Almac Showcases Fully Integrated Suite of e-technologies at Partnerships with CROs and EDC & Beyond
February 26, 2008 Almac Inks 15-Year Deal with Affy to Secure Rights to Develop and Sell Array-Based Dxs
October 15, 2007 Northern Ireland First Minister Commends Almac as a World Class Pharmaceutical Organisation
August 8, 2007 Almac Diagnostic Services Announces Pioneering Genetic Research on Ductal Carcinoma In Situ (DCIS) Using Breast Cancer DSA™ Research Tool
July 31, 2007 Almac Clinical Technologies Launches IXR Express: A new way for clients to accelerate the clinical trial process
May 31, 2007 Almac Diagnostic Services Attends Pre-ide Meeting With FDA for Colorectal Cancer Diagnostic Derived from FFPE Tissue Craigavon, Northern Ireland, 28 May 2007
May 31, 2007 Prof Patrick Johnston of Queen’s University Belfast & Almac Diagnostic Services honoured by President McAleese
September 5, 2006 Almac Clinical Technologies Celebrates Successful Launch of Drug Reconciliation Tool
